JP Morgan Chase’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.26B | Sell |
5,767,731
-6,442,030
| -53% | -$1.78B | 0.07% | 242 |
|
|
2026
Q1 | $3.63B | Buy |
12,209,761
+1,108,304
| +10% | +$329M | 0.23% | 93 |
|
|
2025
Q4 | $3.03B | Buy |
11,101,457
+1,559,916
| +16% | +$424M | 0.19% | 115 |
|
|
2025
Q3 | $2.58B | Sell |
9,541,541
-2,744,851
| -22% | -$747M | 0.15% | 135 |
|
|
2025
Q2 | $3.39B | Sell |
12,286,392
-287,720
| -2% | -$78.2M | 0.22% | 96 |
|
|
2025
Q1 | $3.34B | Buy |
12,574,112
+1,780,700
| +16% | +$439M | 0.24% | 93 |
|
|
2024
Q4 | $2.51B | Buy |
10,793,412
+337,063
| +3% | +$77.5M | 0.19% | 121 |
|
|
2024
Q3 | $2.34B | Sell |
10,456,349
-1,110,560
| -10% | -$230M | 0.18% | 125 |
|
|
2024
Q2 | $2.27B | Sell |
11,566,909
-3,489,179
| -23% | -$721M | 0.19% | 115 |
|
|
2024
Q1 | $3.24B | Buy |
15,056,088
+468,070
| +3% | +$98.3M | 0.27% | 80 |
|
|
2023
Q4 | $3.07B | Sell |
14,588,018
-3,137,809
| -18% | -$670M | 0.29% | 76 |
|
|
2023
Q3 | $3.55B | Buy |
17,725,827
+1,741,273
| +11% | +$346M | 0.39% | 55 |
|
|
2023
Q2 | $2.96B | Buy |
15,984,554
+885,721
| +6% | +$164M | 0.32% | 69 |
|
|
2023
Q1 | $2.89B | Buy |
15,098,833
+2,155,885
| +17% | +$390M | 0.35% | 66 |
|
|
2022
Q4 | $2.18B | Buy |
12,942,948
+4,078,610
| +46% | +$709M | 0.29% | 91 |
|
|
2022
Q3 | $1.57B | Buy |
8,864,338
+2,237,145
| +34% | +$442M | 0.23% | 105 |
|
|
2022
Q2 | $1.36B | Sell |
6,627,193
-824,013
| -11% | -$175M | 0.19% | 124 |
|
|
2022
Q1 | $1.77B | Sell |
7,451,206
-708,399
| -9% | -$166M | 0.21% | 110 |
|
|
2021
Q4 | $1.86B | Buy |
8,159,605
+55,537
| +0.7% | +$12.2M | 0.22% | 102 |
|
|
2021
Q3 | $1.57B | Sell |
8,104,068
-133,027
| -2% | -$27M | 0.19% | 124 |
|
|
2021
Q2 | $1.75B | Buy |
8,237,095
+327,764
| +4% | +$69.2M | 0.21% | 107 |
|
|
2021
Q1 | $1.62B | Sell |
7,909,331
-180,687
| -2% | -$35.6M | 0.22% | 105 |
|
|
2020
Q4 | $1.47B | Buy |
8,090,018
+845,485
| +12% | +$144M | 0.22% | 108 |
|
|
2020
Q3 | $1.2B | Sell |
7,244,533
-1,210,239
| -14% | -$204M | 0.2% | 109 |
|
|
2020
Q2 | $1.37B | Buy |
8,454,772
+314,589
| +4% | +$56.4M | 0.27% | 78 |
|
|
2020
Q1 | $1.41B | Buy |
8,140,183
+1,476,313
| +22% | +$294M | 0.33% | 66 |
|
|
2019
Q4 | $1.34B | Buy |
6,663,870
+440,605
| +7% | +$90.4M | 0.25% | 84 |
|
|
2019
Q3 | $1.32B | Sell |
6,223,265
-300,014
| -5% | -$62.7M | 0.26% | 73 |
|
|
2019
Q2 | $1.26B | Buy |
6,523,279
+412,090
| +7% | +$76M | 0.25% | 83 |
|
|
2019
Q1 | $1.01B | Sell |
6,111,189
-525,110
| -8% | -$92.8M | 0.21% | 105 |
|
|
2018
Q4 | $1.25B | Buy |
6,636,299
+704,760
| +12% | +$130M | 0.29% | 72 |
|
|
2018
Q3 | $1.01B | Sell |
5,931,539
-227,104
| -4% | -$38.2M | 0.19% | 114 |
|
|
2018
Q2 | $1.01B | Buy |
6,158,643
+239,630
| +4% | +$39.1M | 0.21% | 101 |
|
|
2018
Q1 | $957M | Sell |
5,919,013
-192,771
| -3% | -$30.7M | 0.21% | 109 |
|
|
2017
Q4 | $893M | Sell |
6,111,784
-40,770
| -0.7% | -$5.81M | 0.19% | 116 |
|
|
2017
Q3 | $836M | Sell |
6,152,554
-140,810
| -2% | -$17.8M | 0.18% | 113 |
|
|
2017
Q2 | $788M | Sell |
6,293,364
-1,292,754
| -17% | -$155M | 0.18% | 120 |
|
|
2017
Q1 | $901M | Buy |
7,586,118
+830,566
| +12% | +$99.9M | 0.21% | 96 |
|
|
2016
Q4 | $779M | Sell |
6,755,552
-309,393
| -4% | -$34.4M | 0.19% | 121 |
|
|
2016
Q3 | $738M | Buy |
7,064,945
+88,456
| +1% | +$9.23M | 0.18% | 123 |
|
|
2016
Q2 | $680M | Buy |
6,976,489
+249,481
| +4% | +$23.6M | 0.17% | 136 |
|
|
2016
Q1 | $646M | Sell |
6,727,008
-561,451
| -8% | -$51.1M | 0.17% | 147 |
|
|
2015
Q4 | $660M | Sell |
7,288,459
-112,380
| -2% | -$10.6M | 0.17% | 145 |
|
|
2015
Q3 | $686M | Sell |
7,400,839
-171,612
| -2% | -$16.3M | 0.18% | 124 |
|
|
2015
Q2 | $705M | Sell |
7,572,451
-134,321
| -2% | -$12.5M | 0.17% | 147 |
|
|
2015
Q1 | $730M | Buy |
7,706,772
+418,064
| +6% | +$38.7M | 0.17% | 139 |
|
|
2014
Q4 | $646M | Buy |
7,288,708
+583,026
| +9% | +$49.4M | 0.15% | 161 |
|
|
2014
Q3 | $536M | Sell |
6,705,682
-913,034
| -12% | -$68.8M | 0.13% | 177 |
|
|
2014
Q2 | $541M | Buy |
7,618,716
+2,219,337
| +41% | +$156M | 0.14% | 161 |
|
|
2014
Q1 | $400M | Buy |
5,399,379
+78,715
| +1% | +$5.94M | 0.11% | 202 |
|
|
2013
Q4 | $417M | Sell |
5,320,664
-157,214
| -3% | -$12.3M | 0.12% | 199 |
|
|
2013
Q3 | $405M | Sell |
5,477,878
-423,760
| -7% | -$31.2M | 0.12% | 200 |
|
|
2013
Q2 | $448M | Buy |
+5,901,638
| New | +$387M | 0.14% | 163 |
|
Other funds holding CME
AI
JP Morgan Chase's CME Position: Q2 2026 in Review
JP Morgan Chase reduced its CME Group (CME) stake by 53% in Q2 2026, selling an estimated $1.78B and leaving 5,767,731 shares worth $1.26B. The position accounts for 0.07% of the portfolio, ranked #242.
JP Morgan Chase first reported a position in CME in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.63B in Q1 2026. 1,231 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- JP Morgan Chase held 5,767,731 shares of CME Group worth $1.26B as of Q2 2026.
- JP Morgan Chase sold 6,442,030 CME Group shares in Q2 2026, an estimated $1.78B.
- CME Group made up 0.07% of JP Morgan Chase's portfolio in Q2 2026, its #242 holding.
- JP Morgan Chase first reported a position in CME Group in Q2 2013 and has held it in 53 quarters since.
- JP Morgan Chase's CME Group position peaked at $3.63B in Q1 2026.
- 1,231 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.